Cohort profile update: The Canadian Maternal–Infant Research on Environmental Chemicals Child Development study (MIREC‐CD PLUS)

Abstract

BackgroundThe pan‐Canadian Maternal–Infant Research on Environmental Chemicals (MIREC) study was established to determine whether maternal environmental chemical exposures were associated with adverse pregnancy outcomes in 2001 pregnant women.ObjectivesThe MIREC‐Child Development (CD PLUS) study followed this cohort with the goal of assessing the potential effects of prenatal exposures on anthropometry and neurodevelopment in early childhood.PopulationMIREC families with children between the ages of 15 months and 5 years who had agreed to be contacted for future research (n = 1459) were invited to participate in MIREC–CD PLUS which combines data collected from an online Maternal Self‐Administered Questionnaire with biomonitoring and neurodevelopment data collected from two in‐person visits.Preliminary ResultsBetween April 2013 and March 2015, 803 children participated in the Biomonitoring visit where we collected anthropometric measures, blood, and urine from the children. The Behavioural Assessment System for Children‐2, Behaviour Rating Inventory of Executive Function, MacArthur‐Bates Communicative Development Inventories and the Communication subscale of the Adaptive Behaviour Scale from the Bayley Scales of Infant and Toddler Development‐III are available on close to 900 children. There were 610 singleton children who completed in‐person visits for neurodevelopment assessments including the Social Responsiveness Scale, Wechsler Preschool Primary Scale of Intelligence‐III and NEuroPSYchological assessments (NEPSY). Currently, we are following the cohort into early adolescence to measure the impact of early life exposures on endocrine and metabolic function (MIREC–ENDO).ConclusionsData collection for the MIREC–CD PLUS study is complete and analysis of the data continues. We are now extending the follow‐up of the cohort into adolescence to measure the impact of early life exposures on endocrine and metabolic function (MIREC–ENDO). MIREC–CD PLUS is limited by loss to follow‐up and the fact that mothers are predominately of higher socioeconomic status and ‘White’ ethnicity, which limits our generalizability. However, the depth of biomonitoring and clinical measures in MIREC provides a platform to examine associations of prenatal, infancy and childhood exposures with child growth and development.

Serum concentrations of legacy, alternative, and precursor per- and polyfluoroalkyl substances: a descriptive analysis of adult female participants in the MIREC-ENDO study

“…Informed consent was obtained from all participants. Of the participants recruited for the MIREC study ( n = 2001), this analysis was restricted to the subset of participants that attended a clinic visit for the follow-up study and provided a blood sample [ 36 ]. Overall, 308 participants attended a clinic visit and 289 of these participants provided a blood sample.…”